REICIN ALISE 4

What Happened
Reicin Alise, a director of Immatics N.V. (IMTX), was granted 48,000 derivative securities (reported as an award/acquisition) on June 16, 2026. The filing reports a price of $0.00 and a total reported acquisition value of $0 — this reflects a grant of options/awards, not an open‑market purchase or sale.

Key Details

• Transaction date: 2026-06-16; Form 4 filed: 2026-06-18 (timely filing).
• Reported transaction: Award/Grant (derivative) of 48,000 shares; reported price $0.00, reported value $0.
• Shares owned after transaction: Not specified in the Form 4 filing.
• Footnote: F1 — "These Options vest 100% on the first anniversary of the grant date, June 16, 2026." (per the filing).
• No sale or exercise recorded in this filing; this is a grant of rights to acquire equity in the future.

Context
This was an equity award (derivative grant), meaning Alise received options or similar rights rather than purchasing or selling stock immediately. Such grants typically vest over time (see footnote) and only become share ownership if/when exercised per the plan terms; the filing does not indicate exercise, sale, or immediate cash value.